Poliovirus replicons encoding therapeutic agents and uses thereof
CA 2409190 A1 · Owner: Jackson, Cheryl · Inventors: Morrow, Casey D.; Jackson, Cheryl; Peduzzi, Jean
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention pertains to methods of delivering a polypeptide to a cell comprising: (a) contacting a cell with a replicon having a non-poliovirus nucleic acid substituted for a nucleic acid which encodes at least a portion of a protein necessary for encapsidation the non-poliovirus nucleic acid , encoding in an expressible form, a polypeptide or fragment thereof; and (b) maintaining the cells under conditions appropriate for introduction of the replicons into the cells. The cell may be within a subject and the polypeptide may be a therapeutic agent. The methods of the invention may be used to treat diseases including central nervous system disorders infectious diseases, and , cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 13, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.